Evaluation of Antibacterial and Antiviral Drug Effectiveness in COVID-19 Therapy: A Data-Driven Retrospective Approach

The clinical manifestations associated with COVID-19 disease is mainly due to a dysregulated host response related to the overexpression of inflammatory markers. Until recently, only remdesivir had gained FDA approval for COVID-19 hospitalized patients and there are currently no evidence-based thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Yulia, Rika, Ikasanti, Putri Ayu Irma, Herawati, Fauna, Hartono, Ruddy, Hanum, Puri Safitri, Lestiono, Ramdani, Dewi, Jaelani, Abdul Kadir, Kantono, Kevin, Wijono, Heru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955219/
https://www.ncbi.nlm.nih.gov/pubmed/35366292
http://dx.doi.org/10.3390/pathophysiology29010009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955219/
https://www.ncbi.nlm.nih.gov/pubmed/35366292
http://dx.doi.org/10.3390/pathophysiology29010009

Ejemplares similares